Shu‐Fen Liao
Papers
1
Total Citations
13
H-Index
1
About
Shu-Fen Liao is a clinical researcher whose work focuses on improving surgical outcomes for patients with pheochromocytoma (PCC), a rare adrenal tumor that poses significant perioperative risks. Her key research area centers on predicting and managing intraoperative hemodynamic instability (IHD), a life-threatening complication during PCC resection. Liao’s major contribution is the development and validation of a nomogram—a predictive tool that integrates clinical and biochemical parameters to forecast IHD risk before surgery. This work, published in 2022 and already cited 13 times, offers surgeons a practical, evidence-based method to stratify patients and tailor intraoperative management, potentially reducing mortality and morbidity. By addressing a critical gap in perioperative care for PCC, Liao’s research has direct clinical impact, guiding decisions in open, laparoscopic, and robot-assisted adrenalectomy. Her achievement lies in translating complex risk factors into an accessible scoring system, advancing precision medicine in endocrine surgery. For students and researchers, Liao’s work exemplifies how targeted predictive modeling can enhance safety in high-risk procedures, making her a notable contributor to surgical oncology and anesthesiology.
Research Focus
Key Achievements
Top Papers
- 1